MMRI Publishes Breakthrough Study Detailing a Novel Approach to Minimize Damage After a Heart Attack
DAIC
DECEMBER 20, 2023
The manuscript details how, when targeted specifically to the spleen, histone deacetylase (HDAC) inhibitors, chemical compounds that can be used to treat cancers and other diseases, have the potential to improve the healing response following a heart attack. MMRI scientists who contributed to the study include Jason R.
Let's personalize your content